Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Fukuda

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|April 2, 2008
Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23Eriko Ogura, Kazunori Kageyama, Seiji Fukumoto, et al.
Scientific Reports|August 17, 2019
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degenerationYoshiko Fukuda, Yoichi Sakurada, Seigo Yoneyama, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Neuroscience Research|February 8, 2003
Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vectorYoshiko Fukuda, Jun-ichi Yamamura, Teruko Uwano, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2020
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular DegenerationTaiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, et al.
Journal of Clinical Medicine|August 6, 2020
Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Atsushi Sugiyama, et al.
Retina (Philadelphia, Pa.)|February 20, 2024
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata RegimenWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Antiviral Chemistry & Chemotherapy|December 26, 2003
In vitro and in vivo activities of T-705 and oseltamivir against influenza virusKazumi Takahashi, Yousuke Furuta, Yoshiko Fukuda, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2016
T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2Hiroshi Nishikawa, Toru Sakagami, Eio Yamada, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|April 2, 2008
Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23Eriko Ogura, Kazunori Kageyama, Seiji Fukumoto, et al.
Scientific Reports|August 17, 2019
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degenerationYoshiko Fukuda, Yoichi Sakurada, Seigo Yoneyama, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Neuroscience Research|February 8, 2003
Regulated transgene delivery by ganciclovir in the brain without physiological alterations by a live attenuated herpes simplex virus vectorYoshiko Fukuda, Jun-ichi Yamamura, Teruko Uwano, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2020
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular DegenerationTaiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, et al.
Journal of Clinical Medicine|August 6, 2020
Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Atsushi Sugiyama, et al.
Retina (Philadelphia, Pa.)|February 20, 2024
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata RegimenWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Antiviral Chemistry & Chemotherapy|December 26, 2003
In vitro and in vivo activities of T-705 and oseltamivir against influenza virusKazumi Takahashi, Yousuke Furuta, Yoshiko Fukuda, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2016
T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2Hiroshi Nishikawa, Toru Sakagami, Eio Yamada, et al.
Pageof 7